Management of Potential Long-Term Toxicities in Breast Cancer Patients

Breast cancer is the most common non-cutaneous malignancy among women, and there are over 3 million breast cancer survivors living in the USA today. Excellent cure rates with modern therapies are associated with substantial toxicities for many women; it is important that healthcare providers attend to the resulting symptoms and issues to optimize quality of life in this population. In this article, we review management options for potential long-term toxicities in breast cancer survivors, with a particular focus on bone health, fertility preservation, premature menopause, cardiac dysfunction, and cognitive impairment.